Nancy Tricoche

Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients

Larry L. Luchsinger, Brett Ransegnola, Daniel Jin et al. · Journal of Clinical Microbiology · 2020 · 178 citations · Full text

Vaccination, Modest Antibody Levels, Long Covid +12

Drugs that target early stages of Onchocerca volvulus: A revisited means to facilitate the elimination goals for onchocerciasis

S Jawahar, Nancy Tricoche, Christina A. Bulman et al. · PLoS neglected tropical diseases · 2021 · 140 citations · Full text

Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate

Wen‐Hsiang Chen, Lanying Du, Shivali Chag et al. · Human Vaccines & Immunotherapeutics · 2013 · 128 citations · Full text

Vaccination, Rbd Vaccine Candidate, Vaccine Development +15

Repurposing Auranofin as a Lead Candidate for Treatment of Lymphatic Filariasis and Onchocerciasis

Christina A. Bulman, Chelsea M. Bidlow, Sara Lustigman et al. · PLoS neglected tropical diseases · 2015 · 104 citations · Full text

Parasitic Disease, Ic50 Values, Lead Candidate +12

Repositioning of an existing drug for the neglected tropical disease Onchocerciasis

Christian Johannes Gloeckner, Amanda L. Garner, Fana B. Mersha et al. · Proceedings of the National Academy of Sciences · 2010 · 102 citations · Full text